Combination Therapy for Type II Diabetics

Posts Related to Combination Therapy for Type II Diabetics

• Viagra (sildenafil): Safe and Effective for Those With Diabetes

  The big brouhaha over Viagra (sildenafil) has pretty much settled down, but that doesn't mean we know everything there is to know about it. Three studies were presented at the scientific sessions of the American Diabetes Association in San Antonio, Texas, reporting that the first oral medication for treating erectile dysfunction is safe and effective ...

• Current Oral Antidiabetic Therapy: Thiazoudinediones

  Thiazolidinediones were developed in Japan and have been available in the United States since March 1997. Today, more than 600,000 people in the United States are being treated with troglitazone. Until recently, troglitazone was the only available member of this group. Troglitazone Brand Name Drug: Rezulin, Resulin or Romozin Troglitazone has been shown to improve ...

• Drug Pioglitazone (Actos) for oral treatment of type 2 diabetes

  FDA approved pioglitazone (Actos) for oral treatment of type 2 diabetes. Developed by Takeda America, pioglitazone becomes the third thiazolidinedione insulin-sensitizing agent to reach the U.S. market. To be comarketed with Eli Lilly and Company, pioglitazone is indicated for once-daily treatment of patients with type 2 diabetes as monotherapy or in combination with sulfonylureas, metformin, ...

• Insulin Resistance: Nonglycemic Effects of Thiazolidinediones

  Both pioglitazone and rosiglitazone have been shown to increase HDL levels, and pioglitazone has also been shown to decrease triglyceride levels. Data indicate that pioglitazone raises HDL levels by up to 19% and decreases triglyceride levels by up to 15% relative to baseline. Data on rosiglitazone from a 52-week study indicate mean significant increases in ...

• Insulin Resistance: Insulin Sensitizers in Clinical Practice

  The two thiazolidinediones approved for use in type 2 diabetes are rosiglitazone and pioglitazone. These agents became available in 1999 and are approved as monotherapy and in combination with sulfonylurea or metformin for the treatment of type 2 diabetes. Pioglitazone is also approved in combination with insulin. Troglitazone (Rezulin),which was the first member of this ...